Last reviewed · How we verify
arterial blood gas measurement each morning
arterial blood gas measurement each morning is a Biologic drug developed by University Hospital, Angers. It is currently in Phase 1 development.
At a glance
| Generic name | arterial blood gas measurement each morning |
|---|---|
| Sponsor | University Hospital, Angers |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Low-flow Versus Minimal-flow Sevoflurane Anesthesia During Robot-assisted Laparoscopic Radical Prostatectomy (NA)
- The Influence of Cardiorespiratory Fitness on Firefighter Cardiovascular Health Under Exercise Conditions (NA)
- Early Spontaneous Breathing in Acute Respiratory Distress Syndrome (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- arterial blood gas measurement each morning CI brief — competitive landscape report
- arterial blood gas measurement each morning updates RSS · CI watch RSS
- University Hospital, Angers portfolio CI
Frequently asked questions about arterial blood gas measurement each morning
What is arterial blood gas measurement each morning?
arterial blood gas measurement each morning is a Biologic drug developed by University Hospital, Angers.
Who makes arterial blood gas measurement each morning?
arterial blood gas measurement each morning is developed by University Hospital, Angers (see full University Hospital, Angers pipeline at /company/university-hospital-angers).
What development phase is arterial blood gas measurement each morning in?
arterial blood gas measurement each morning is in Phase 1.